Nicolaus Kröger - Concepedia

Author

Nicolaus Kröger

Also Known As

N Kröger, N. Kroger, N. Kröger, N., Kröger, Nicolaus Kroger, Nicolaus Krogër, Nicolaus Kröger, Nicolaus Kröger, Nicolaus M. Kröger, R Schwerdtfeger

156

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Universität Hamburg University Medical Center Hamburg-Eppendorf European Society for Blood and Marrow Transplantation Hôpital Saint-Louis Heidelberg University

About

Nicolaus Kröger is an author at Universität Hamburg specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	297
2	Health Sciences	4	4	180
3	Anesthesia	1	1	11
4	Biostatistics	1	1	33
5	Blood Transplantation	1	1	37

Nicolaus Kröger

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation Djordje Atanackovic, Julia Arfsten, Yanran Cao, Blood	2006	157
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group Anne M. Spanjaart, Per Ljungman, Rafael de la Cámara, Leukemia	2021	112
Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells Djordje Atanackovic, York Hildebrandt, Adam Jadczak, Haematologica	2009	97
Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12 Axel Vater, Jörg Sahlmann, Nicolaus Kröger, Clinical Pharmacology & Therapeutics	2013	85
Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis Haefaa Alchalby, Dr. Md. Yunus, Tatjana Zabelina, Bone Marrow Transplantation TransplantationMarrow TransplantationHealth SciencesBone Marrow FailureStem Cell Transplantation	2016	71
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma Nico Gagelmann, Danai Dima, Maximilian Merz, Journal of Clinical Oncology	2024	70
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study Hildegard Greinix, Dirk‐Jan Eikema, Linda Köster, Haematologica	2021	65
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma Djordje Atanackovic, Jens Panse, York Hildebrandt, Haematologica	2011	64
Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy Heinrich Lellek, Gefion Franke, Carolin Ruckert, International Journal of Medical Microbiology Daptomycin TherapyAntimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesAntibiotics	2015	52
CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study Joseph P. McGuirk, Constantine S. Tam, Nicolaus Kröger, Blood Lymphoid NeoplasiaImmunologyCell TransplantationImmune Cell TherapyImmunotherapy	2022	47

Page 1